Literature DB >> 10861447

Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.

U B Hofmann1, J R Westphal, A A Van Kraats, D J Ruiter, G N Van Muijen.   

Abstract

Activation of matrix metalloproteinase-2 (MMP-2) is mediated by binding to the complex of membrane-type matrix metalloproteinase-1 (MT1-MMP) with tissue inhibitor of MMP-2 (TIMP-2) on the cell surface. Binding of MMP-2 to integrin alpha(v)beta(3) has been implicated in presenting activated MMP-2 on the cell surface of invasive cells, but interactions with the MT1-MMP-TIMP-2 system have not been considered. Therefore, we studied the expression and interaction of MT1-MMP, MMP-2 and TIMP-2 in the alpha(v)beta(3)-negative melanoma cell line BLM and in its beta(3)-transfected, alpha(v)beta(3)-expressing counterpart BLM-beta(3), both on cell lines and in xenografts. Total expression levels of MMP-2, MT1-MMP and TIMP-2 did not differ markedly between the alpha(v)beta(3)-negative and alpha(v)beta(3)-positive cells. Remarkable differences, however, exist in the presence of active MMP-2 and MT1-MMP. Zymography on cell lysates revealed that active MMP-2 was restricted to alpha(v)beta(3)-positive cell line and clearly accumulated in xenografts derived from the BLM-beta(3) cells, confirming the relevance of this integrin for MMP-2 function. Western blotting of cell lysates showed that processing of proMT1-MMP to the activated form was enhanced in BLM-beta(3). The ratio of active and inactive MT1-MMP was 3-fold higher in the beta(3)-transfectants. Immunofluorescence double-labeling followed by confocal laser microscopy showed co-localization of MT1-MMP and alpha(v)beta(3) on BLM-beta(3) cells. In xenografts from BLM-beta(3) cells, active MT1-MMP was markedly increased. Our results demonstrate that expression of alpha(v)beta(3) in cell lines and xenografts was accompanied by an accumulation of active MT1-MMP and MMP-2. Furthermore, MT1-MMP and alpha(v)beta(3) are co-localized on the cell membrane of tumor cells. These findings suggest that activated MT1-MMP co-localized with alpha(v)beta(3) may be involved in activation of alpha(v)beta(3)-bound MMP-2. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861447     DOI: 10.1002/1097-0215(20000701)87:1<12::aid-ijc3>3.0.co;2-a

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.

Authors:  Rubén A Bartolomé; Isabel Molina-Ortiz; Rafael Samaniego; Paloma Sánchez-Mateos; Xosé R Bustelo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Authors:  Gentian Lluri; Garret D Langlois; Paul D Soloway; Diane M Jaworski
Journal:  Exp Cell Res       Date:  2007-06-27       Impact factor: 3.905

3.  BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression.

Authors:  Hanan S Elsarraj; Yan Hong; Darlene Limback; Ruonan Zhao; Jenna Berger; Stephanie C Bishop; Aria Sabbagh; Linzi Oppenheimer; Haleigh E Harper; Anna Tsimelzon; Shixia Huang; Susan G Hilsenbeck; Dean P Edwards; Joseph Fontes; Fang Fan; Rashna Madan; Ben Fangman; Ashley Ellis; Ossama Tawfik; Diane L Persons; Timothy Fields; Andrew K Godwin; Christy R Hagan; Katherine Swenson-Fields; Cristian Coarfa; Jeffrey Thompson; Fariba Behbod
Journal:  NPJ Breast Cancer       Date:  2020-04-24

4.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

5.  Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells.

Authors:  E B Voura; R A Ramjeesingh; A M Montgomery; C H Siu
Journal:  Mol Biol Cell       Date:  2001-09       Impact factor: 4.138

6.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Authors:  E Toschi; G Barillari; C Sgadari; I Bacigalupo; A Cereseto; D Carlei; C Palladino; C Zietz; P Leone; M Stürzl; S Buttò; A Cafaro; P Monini; B Ensoli
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

7.  Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2.

Authors:  Aparna Mitra; Jayati Chakrabarti; Aniruddha Banerji; Shamik Das; Amitava Chatterjee
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-26       Impact factor: 4.553

8.  Selective inhibition of nuclear factor-κB by nuclear factor-κB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma.

Authors:  Takuya Tanaka; Hideki Nakayama; Yoshihiro Yoshitake; Atsushi Irie; Masashi Nagata; Kenta Kawahara; Yasuo Takamune; Ryoji Yoshida; Yoshihiro Nakagawa; Hidenao Ogi; Satoru Shinriki; Kazutoshi Ota; Akimitsu Hiraki; Tetsuro Ikebe; Yasuharu Nishimura; Masanori Shinohara
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

Review 9.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

10.  Lymphatic Contribution to the Cellular Niche in Heterotopic Ossification.

Authors:  Shawn Loder; Shailesh Agarwal; Michael Sorkin; Chris Breuler; John Li; Joshua Peterson; Jason Gardenier; Hsiao Hsin Sung Hsieh; Stewart C Wang; Babak J Mehrara; Benjamin Levi
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.